Published 8th September 2017

Inivata appoints Chief Operations Officer

Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, has appointed Dr Jamie Platt as Chief Operations Officer.  Jamie will be based at Research Triangle Park, NC, and will drive operational excellence across the organization, including both the UK and the US CLIA laboratories.

Jamie brings 15 years of successful clinical diagnostics laboratory leadership experience, having directed the development and validation of numerous high complexity sequencing assays in the clinical areas of Oncology, Infectious Disease and Molecular Genetics. During her tenure at Quest Diagnostics, she drove the early Advanced Sequencing strategy and product portfolio, and further ensured operational success by leveraging industrial-grade high-throughput automation, Six Sigma and Lean.

Jamie received her Ph.D. in Molecular and Cellular Biology from Oregon State University and completed postdoctoral training in population genetics at the University of California, Berkeley.

Dr Jamie Platt, Chief Operations Officer, said:

“It’s an exciting time to be joining Inivata. The Company’s InVision liquid biopsy platform is exceptionally sensitive and I look forward to working with the team as we build on its potential, not just in helping physicians to stratify and better treat patients, but in expanding the use of liquid biopsies in monitoring and future applications.”

Read Inivata's statement